- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01632644
Identifying Skin Biopsy Sites
December 2, 2021 updated by: Murad Alam, Northwestern University
Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews
The primary objective of this study is to investigate the patient experience during skin biopsy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
59
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Physicians will be recruited by email obtained through directories.
Patients will be those who have had biopsies at the Northwestern University Department of Dermatology.
Description
Inclusion Criteria:
- Age 18 and Over
- The subjects are in good health.
- The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
- Patients who have had one or multiple skin biopsies OR board-certified dermatologists.
Exclusion Criteria:
- Under 18 years of age.
- Subjects who are unable to understand the protocol or give informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Physicians
Physicians performing skin biopsies
|
Each group will be surveyed and interviewed.
|
|
Patients
Patients who have had skin biopsies
|
Each group will be surveyed and interviewed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Review of Physician and Patient Experience
Time Frame: Last four weeks of study
|
Subjects will answer a combination of:
|
Last four weeks of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physician's Experience with Skin Biopsy Sites
Time Frame: First four weeks of study
|
Physicians will answer a combination of:
|
First four weeks of study
|
|
Patient's Experience with Skin Biopsy Sites
Time Frame: First four weeks of study
|
Patients will answer a combination of:
|
First four weeks of study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
June 27, 2012
First Submitted That Met QC Criteria
June 28, 2012
First Posted (Estimate)
July 3, 2012
Study Record Updates
Last Update Posted (Actual)
December 6, 2021
Last Update Submitted That Met QC Criteria
December 2, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU66384
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Identification of Skin Cancer Biopsy Sites
-
Klinik BogenhausenCompletedReepithelialization of Skin Graft Donor SitesGermany
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
Poitiers University HospitalCompletedIdentification of the Mother or Fetus Contamination by SARS Cov-2 | Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father | The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes | Analysis Laboratories of the Poitiers...France
-
The First Affiliated Hospital with Nanjing Medical...CompletedLocation and Biopsy of Axillary Lymph NodesChina
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedArthritis, Rheumatoid | Healthy People | Disorders of Synovium, Multiple Sites | Disorders of Subchondral Bone, Multiple Sites | Disorders of Cartilage, Hand Joints
-
Dune Medical DevicesUnknown
-
Hospital Universitario 12 de OctubreCompleted
-
Syantra Inc.University of CalgaryRecruitingBreast Cancer, Liquid Biopsy, Early DetectionUnited Kingdom, United States, Canada
-
University of Campania "Luigi Vanvitelli"RecruitingBreast Cancer | Liquid BiopsyItaly
-
Novosanis NVUniversiteit AntwerpenRecruitingBreast Cancer | Prostate Cancer | Urine | Liquid BiopsyBelgium
Clinical Trials on Survey/Interview
-
The Royal Wolverhampton Hospitals NHS TrustCompleted
-
M.D. Anderson Cancer CenterCompletedAdvanced CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnCholangiocarcinoma | Breast Carcinoma | Gastric Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Malignant Digestive System NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminatedCervical Cancer | Gastric Cancer | Pancreatic Cancer | Vulvar Cancer | Endometrial Cancer | Anal CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedTobacco Use CessationUnited States
-
Manchester University NHS Foundation TrustWithdrawnStaff AttitudeUnited Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
Washington University School of MedicineCompleted